AI assistant
Sending…
ABBOTT LABORATORIES — Director's Dealing 2024
Mar 5, 2024
29777_dirs_2024-03-04_236192ee-c5c1-4c50-8726-daa1cfb6bac8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2024-02-29
Reporting Person: Funck, Jr. Robert E. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-29 | Common shares without par value | F | 11415 | $120.05 | Disposed | 211341 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common shares without par value | 20000 | Indirect |
| Common shares without par value | 20000 | Indirect |
| Common shares without par value | 18765 | Indirect |
| Common shares without par value | 500 | Indirect |
Footnotes
F1: Held in daughter's annual gift trust. The reporting person disclaims beneficial ownership of all securities held by the trust.
F2: Balance in the Abbott Laboratories Stock Retirement Trust as of March 1, 2024.
F3: The reporting person disclaims beneficial ownership of all securities held by his daughter.
More from ABBOTT LABORATORIES
Regulatory Filings
2026
May 27
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 24
Legal Proceedings Report
2026
Apr 17
Earnings Release
2026
Apr 16
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 25